Total Payments
$176.26
2021 Payments
$39.48
Companies
5
Transactions
13
Medicare Patients
1,444
Medicare Billing
$225,428
Payment Breakdown by Category
Food & Beverage$176.26 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $176.26 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $75.56 | 6 | $0 (2020) |
| Novo Nordisk Inc | $39.48 | 2 | $0 (2021) |
| PFIZER INC. | $38.13 | 3 | $0 (2019) |
| Medtronic MiniMed, Inc. | $12.62 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $10.47 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $39.48 | 2 | Novo Nordisk Inc ($39.48) |
| 2020 | $14.32 | 1 | Amgen Inc. ($14.32) |
| 2019 | $24.38 | 2 | PFIZER INC. ($24.38) |
| 2018 | $50.66 | 4 | Amgen Inc. ($38.04) |
| 2017 | $47.42 | 4 | Amgen Inc. ($23.20) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Obesity | ||||||
| 04/30/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Obesity | ||||||
| 02/07/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiology | ||||||
| 08/09/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/24/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Neuroscience | ||||||
| 08/10/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Endocrinology | ||||||
| 03/28/2018 | Medtronic MiniMed, Inc. | iPro2 (Device) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 03/23/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Endocrinology | ||||||
| 10/06/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Endocrinology | ||||||
| 07/14/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Endocrinology | ||||||
| 05/03/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH, CHANTIX | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 265 | 692 | $139,745 | $45,733 |
| 2022 | 10 | 310 | 882 | $177,730 | $56,486 |
| 2021 | 9 | 381 | 877 | $187,780 | $63,165 |
| 2020 | 13 | 488 | 990 | $199,110 | $60,043 |
Total Patients
1,444
Total Services
3,441
Medicare Billing
$225,428
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 143 | $35,600 | $12,934 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 168 | $33,600 | $10,100 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 184 | $23,920 | $7,867 | 32.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 41 | $19,475 | $5,395 | 27.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 26 | 43 | $8,600 | $3,733 | 43.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 67 | $6,700 | $2,039 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 15 | $6,250 | $1,482 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 15 | $2,700 | $1,203 | 44.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 16 | $2,900 | $979.68 | 33.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 341 | $68,200 | $18,719 | 27.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 128 | $32,000 | $9,957 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 165 | $21,450 | $7,508 | 35.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 40 | $19,000 | $6,050 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 51 | $9,180 | $4,433 | 48.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 45 | $9,000 | $3,630 | 40.3% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 18 | 23 | $6,900 | $2,350 | 34.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 61 | $6,100 | $1,958 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,650 | $947.02 | 57.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 17 | $4,250 | $934.51 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 218 | $54,500 | $17,499 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 66 | $31,350 | $10,193 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 168 | $33,600 | $9,222 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 93 | $16,740 | $7,787 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 153 | $19,890 | $7,455 | 37.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 46 | 70 | $14,000 | $5,770 | 41.2% |
About Dr. Dean Blakeley, M.D
Dr. Dean Blakeley, M.D is a Internal Medicine healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376619783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Blakeley, M.D has received a total of $176.26 in payments from pharmaceutical and medical device companies, with $39.48 received in 2021. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($176.26).
As a Medicare-enrolled provider, Blakeley has provided services to 1,444 Medicare beneficiaries, totaling 3,441 services with total Medicare billing of $225,428. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Zebulon, NC
- Active Since 11/28/2006
- Last Updated 08/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376619783
Products in Payments
- Prolia (Biological) $45.42
- CHANTIX (Drug) $24.38
- Wegovy (Drug) $20.60
- Saxenda (Drug) $18.88
- Aimovig (Biological) $15.82
- Repatha (Biological) $14.32
- LYRICA (Drug) $13.75
- iPro2 (Device) $12.62
- XARELTO (Drug) $10.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.